Kane Biotech (KNE) Insider Trading & Ownership C$0.04 -0.01 (-10.00%) As of 12:41 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartEarningsHeadlinesInsider TradesBuy This Stock Kane Biotech (CVE:KNE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage37.21%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)C$279.80KNumber OfInsiders Selling(Last 12 Months)0 Get KNE Insider Trade Alerts Want to know when executives and insiders are buying or selling Kane Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KNE Insider Buying and Selling by Quarter Kane Biotech Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/17/2025Marc EdwardsDirectorBuy2,000,000C$0.10C$200,000.009/13/2024Robert HuizingaDirectorBuy90,000C$0.13C$11,250.007/29/2024Marc EdwardsDirectorBuy150,000C$0.14C$20,250.006/25/2024Marc EdwardsDirectorBuy345,000C$0.14C$48,300.00 (Data available from 1/1/2013 forward) KNE Insider Trading Activity - Frequently Asked Questions Who is on Kane Biotech's Insider Roster? The list of insiders at Kane Biotech includes Marc Edwards, Philip Renaud, Richard J. Renaud, and Robert Huizinga. Learn more on insiders at KNE. What percentage of Kane Biotech stock is owned by insiders? 37.21% of Kane Biotech stock is owned by insiders. Learn more on KNE's insider holdings. Which Kane Biotech insiders have been buying company stock? The following insiders have purchased KNE shares in the last 24 months: Marc Edwards (C$268,550.00), Richard J. Renaud (C$250,000.00), and Robert Huizinga (C$11,250.00). How much insider buying is happening at Kane Biotech? Insiders have purchased a total of 5,710,000 KNE shares in the last 24 months for a total of C$529,800.00 bought. Which Kane Biotech insiders have been selling company stock? The following insider sold KNE shares in the last 24 months: Philip Renaud (C$260,000.00). How much insider selling is happening at Kane Biotech? Insiders have sold a total of 2,000,000 Kane Biotech shares in the last 24 months for a total of C$260,000.00 sold. Kane Biotech Key ExecutivesMr. Marc EdwardsPresident, CEO & Director1 recent tradesMr. Ray DupuisChief Financial OfficerDr. Robert B. Huizinga CNeph(C) (Age 59)M.Sc., MSc(Epi), Ph.D., R.N., RN NNC, Executive Chairman & Member of Scientific Advisory Board Dr. Gregory S. Schultz Ph.D. (Age 74)Chief Scientific Officer & Member of Scientific Advisory Board Lorne GorberInvestor RelationsMs. Wendy NachtigallDirector of MarketingMs. Lori ChristofalosChief Quality OfficerNicole SendeyInvestor Relations Adviser More Insider Trading Tools from MarketBeat Related Companies Hemostemix Insider Trades Quest PharmaTech Insider Trades Innovotech Insider Trades Resverlogix Insider Trades Fennec Pharmaceuticals Insider Trades Theratechnologies Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Tech Stocks With High and Rising Institutional Interest3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for June This page (CVE:KNE) was last updated on 6/24/2025 by MarketBeat.com Staff From Our PartnersIs Tesla a buy right now?Wall Street Legend: Why stocks are very likely to crash in Trump's 2nd Year Legendary investor Marc Chaikin...Chaikin Analytics | SponsoredYour portfolio has a dangerous blind spot (fix it now)The next overnight crash could happen any day. Will you be protected or exposed? Register now to learn how som...Ninjacators | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWall Street is using Bitcoin against youBitcoin is rising again, and institutions are pouring billions into Bitcoin ETFs. At first glance, that mig...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kane Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kane Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KNE Stock Free KNE Stock Alerts